ASCO 2024

Article collection

We are proud to present a special collection of articles for the American Society of Clinical Oncology Annual Meeting 2024. This curated selection showcases the cutting-edge advancements and novel perspectives published in journals from Elsevier's Oncology Journal Network. We invite you to explore this collection and delve deeper into the exciting advancements shaping the future of cancer research.

Annals of Oncology

• ●

  Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040abre em uma nova guia/janela

• ●

  Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]abre em uma nova guia/janela

Blood Neoplasia

• ●

  Patients with Castleman disease report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccinationabre em uma nova guia/janela

Cancer Epidemiology

• ●

  Risk factors for early-onset colorectal cancer: A Canadian prospective cohort studyabre em uma nova guia/janela

• ●

  Metformin’s role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Studyabre em uma nova guia/janela

Cancer Letters

• ●

  Organoid: Bridging the gap between basic research and clinical practiceabre em uma nova guia/janela

• ●

  SPOP-mutant prostate cancer: Translating fundamental biology into patient careabre em uma nova guia/janela

Cancer Pathogenesis and Therapy

• ●

  PI3K/AKT/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancerabre em uma nova guia/janela

• ●

  Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focusabre em uma nova guia/janela

• ●

  Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005–2018)abre em uma nova guia/janela

Cancer Treatment Reviews

• ●

  Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trialsabre em uma nova guia/janela

• ●

  First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United Statesabre em uma nova guia/janela

Clinical Breast Cancer

• ●

  Unlocking the Power of the Homing Phenomenon: Why Breast Conserving Surgery Outshines Mastectomy in Overall Survivalabre em uma nova guia/janela

• ●

  Robotics in Screening, Diagnosis and Treatment of Breast Cancer: A Perspective Viewabre em uma nova guia/janela

• ●

  Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristicsabre em uma nova guia/janela

Clinical Colorectal Cancer

• ●

  Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer Recurrenceabre em uma nova guia/janela

• ●

  Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Reviewabre em uma nova guia/janela

• ●

  A Case of Heavily Pretreated HER2+ Colorectal Liver Metastases Responsive to Hepatic Arterial Infusion Chemotherapyabre em uma nova guia/janela

Clinical Genitourinary Cancer

• ●

  Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapyabre em uma nova guia/janela

• ●

  Cystic Pelvic Masses in Men: A Presentation of Uncommon Cases and a Literature Reviewabre em uma nova guia/janela

• ●

  The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrenceabre em uma nova guia/janela

Clinical Lung Cancer

• ●

  Lung Cancer in Women: The Past, Present, and Futureabre em uma nova guia/janela

• ●

  Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challengesabre em uma nova guia/janela

• ●

  Personalised Assessment and Rapid Intervention in Frail Patients With Lung Cancer: The Impact of an Outpatient Occupational Therapy Serviceabre em uma nova guia/janela

Clinical Lymphoma Myeloma and Leukemia

• ●

  Recommendations for Management of Secondary Antibody Deficiency in Multiple Myelomaabre em uma nova guia/janela

• ●

  Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trialabre em uma nova guia/janela

• ●

  Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtableabre em uma nova guia/janela

Clinics

• ●

  Delayed diagnosis and increased mortality risk: Assessing the effects of the COVID-19 pandemic on breast cancer recurrenceabre em uma nova guia/janela

• ●

  Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapyabre em uma nova guia/janela

• ●

  Prolonged survival after thoracic metastasectomy in patients with nonseminomatous testicular cancerabre em uma nova guia/janela

Critical Reviews in Oncology/Hematology

• ●

  A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classificationsabre em uma nova guia/janela

• ●

  Oncogenic fusions: Targeting NTRKabre em uma nova guia/janela

• ●

  Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeuticsabre em uma nova guia/janela

ESMO Gastrointestinal Oncology

• ●

  Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UKabre em uma nova guia/janela

• ●

  Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational statusabre em uma nova guia/janela

ESMO Open

• ●

  Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer patients with brain metastases from the randomized DESTINY-Breast03 trialabre em uma nova guia/janela

• ●

  Antibody–drug conjugates are active in patients with HER2-positive breast cancer brain metastases: where do we go from here?abre em uma nova guia/janela

ESMO Real World Data and Digital Oncology

• ●

  Toward optimizing patient selection for EGFR antibody therapies in metastatic colorectal cancer: outcomes and resistance features in real-world dataabre em uma nova guia/janela

• ●

  Real-world patterns of treatment and response in metastatic renal cell carcinoma: a multicentre UK-wide review with UK Renal Oncology Collaborative (UK ROC)abre em uma nova guia/janela

Gynecologic Oncology

• ●

  Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 updateabre em uma nova guia/janela

• ●

  Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysisabre em uma nova guia/janela

• ●

  Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancerabre em uma nova guia/janela

• ●

  A personalized probabilistic approach to ovarian cancer diagnosticsabre em uma nova guia/janela

Gynecologic Oncology Reports

• ●

  Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansineabre em uma nova guia/janela

• ●

  The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesiaabre em uma nova guia/janela

• ●

  Quality corner: Safely using cephalosporins in almost all patients with penicillin allergies: Mini-review and suggested protocol to improve efficacy and surgical outcomesabre em uma nova guia/janela

• ●

  Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directionsabre em uma nova guia/janela

Immuno-Oncology and Technology

• ●

  Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: The phase 1 TRIBE trialabre em uma nova guia/janela

• ●

  Engineering approaches for innate immune-mediated tumor microenvironment remodelingabre em uma nova guia/janela

Journal of Cancer Policy

• ●

  Implications of FDA’s marketing authorization of hereditary cancer testingabre em uma nova guia/janela

• ●

  INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomasabre em uma nova guia/janela

Journal of the National Cancer Center

• ●

  Cancer incidence and mortality in China, 2016abre em uma nova guia/janela

• ●

  Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry dataabre em uma nova guia/janela

• ●

  The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapyabre em uma nova guia/janela

Journal of Thoracic Oncology

• ●

  Read here for the Journal of Thoracic Oncology ASCO articles.abre em uma nova guia/janela

Leukemia Research

• ●

  CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123abre em uma nova guia/janela

• ●

  Identification of unique molecular heterogeneity of human CD79, the signaling component of the human B cell antigen receptor (BCR), and synergistic potentiation of the CD79-targeted therapy of B cell tumors by co-targeting of CD79a and CD79babre em uma nova guia/janela

• ●

  The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasmsabre em uma nova guia/janela

Leukemia Research Reports

• ●

  Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomasabre em uma nova guia/janela

• ●

  Myeloid neoplasms in inflammatory bowel disease: A case series and review of the literatureabre em uma nova guia/janela

• ●

  Long-term follow-up of efficacy and safety in elderly patients with chronic myeloid leukemia treated with intermittent low dose dasatinib therapyabre em uma nova guia/janela

Magnetic Resonance Imaging

• ●

  Delineation of the internal iliac vein using MRI with true FISP sequence in patients with locally recurrent rectal cancer: A pilot study using CT/MRI fusionabre em uma nova guia/janela

Neoplasia

• ●

  Interdisciplinary care of children with diffuse midline gliomaabre em uma nova guia/janela

Oral Oncology

• ●

  HER2-targeted therapies for salivary gland cancersabre em uma nova guia/janela

• ●

  Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinomaabre em uma nova guia/janela

Oral Oncology Reports

• ●

  Salivary exosomes as biomarkers for early diagnosis of oral squamous cell carcinomaabre em uma nova guia/janela

Radiation Medicine and Protection

• ●

  Comparison of pencil beam and Monte Carlo calculations with ion chamber array measurements for patient-specific quality assuranceabre em uma nova guia/janela

• ●

  Alzheimer's disease and low-dose radiation therapy: A new hopeabre em uma nova guia/janela

• ●

  Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer (2024 edition)abre em uma nova guia/janela

Seminars in Oncology

• ●

  PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogeneticsabre em uma nova guia/janela

• ●

  PARP inhibitors for prostate cancerabre em uma nova guia/janela

Surgical Oncology Insight

• ●

  The effect of the pandemic on colorectal cancer in the United States: an increased disease burdenabre em uma nova guia/janela

• ●

  Assessing the OPRA Trial for surgical oncologists: Safety and feasibility of a total neoadjuvant therapy approach in patients with rectal cancerabre em uma nova guia/janela

• ●

  Malignant Bowel Obstruction: Historical Lessons, Current Trends, and Future Directionsabre em uma nova guia/janela

• ●

  Implementation of the 2015 American Thyroid Association Guideline Changes Across a Health System: A Quality Improvement Opportunityabre em uma nova guia/janela

The Breast

• ●

  Platinum chemotherapy for early triple-negative breast cancerabre em uma nova guia/janela

• ●

  Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trialabre em uma nova guia/janela

• ●

  Diagnostic delays in breast cancer among young women: An emphasis on healthcare providersabre em uma nova guia/janela

The Journal of Liquid Biopsy

• ●

  Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimensabre em uma nova guia/janela

• ●

  Liquid biopsy: Cell-free DNA based analysis in breast cancerabre em uma nova guia/janela

• ●

  New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insightsabre em uma nova guia/janela

ESMO Podcasts

Listen to the most recent podcasts from the ESMO portfolio.

🎙️ ADCs in HER2+ metastatic breast cancer brain metastases - ESMO Podcastsabre em uma nova guia/janela

🎙️ Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer by ESMO Podcasts (soundcloud.com)

Oncology journal network

We’ll help you find the right home for your research – fast

Publishing your work can be time-consuming, especially if the first journal you submit to isn’t right for your research. With over 40 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters,  Elsevier’s Oncology Journal Network has the right home for your research. And with our transfer service, you’ll benefit from a smooth, simple publishing process.